Medindia

X

Omnicell Announces Second Quarter 2010 Results

Friday, July 23, 2010 General News J E 4
Advertisement

OMNICELL, INC.

CALCULATION OF ADJUSTED EBITDA (1)

(In thousands)

Three Months Ended

Six Months Ended

June 30,    2010

March 31,   2010

June 30,    2009

June 30,     2010

June 30,     2009

GAAP net income (loss)

$         1,965

$            979

$             904

$       2,944

$          (967)

Add back:

ASC 718 stock compensation expense

2,097

2,156

2,374

4,253

4,858

Interest

(88)

(72)

(177)

(160)

(400)

Depreciation and amortization expense

2,178

2,123

2,401

4,301

4,874

Income tax expense (benefit)

1,580

604

607

2,184

(311)

Non-GAAP adjusted EBITDA (1)

$         7,732

$         5,790

$          6,109

$     13,522

$       10,578

(1) Defined as earnings before interest income and expense, taxes, depreciation and amortization,

and non-cash expenses, including stock compensation expense, per ASC 718, formerly FAS 123R.

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Innovative BECOME AN EX Quit Smoking Program Goes ...
S
Anadys Pharmaceuticals to Report Second Quarter 20...